Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine
Collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea, October 8, 2025 — Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics… Read More »Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine





